Navigation Links
Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin
Date:4/22/2009

FDA approval for testing in humans watershed moment for unique malaria

vaccine approach

ROCKVILLE, Md., April 23 /PRNewswire/ -- In a move that highlights the strength of public-private collaboration in tackling international health challenges, the Maryland-based company Sanaria Inc., with support from the PATH Malaria Vaccine Initiative (MVI), has initiated a Phase 1 clinical trial -- the first tests in adult volunteers -- of its unique malaria vaccine candidate. Unlike other malaria vaccine candidates, Sanaria's approach deploys a weakened form of the whole malaria parasite harvested from irradiated mosquitoes instead of small portions of the parasite.

Having met the US Food and Drug Administration's (FDA) rigorous safety, sterility, purity, potency, and reproducibility requirements for testing in humans, Sanaria's vaccine candidate is to be assessed in healthy US volunteers at two sites in Maryland -- the US Naval Medical Research Center Clinical Trials Center in Bethesda and the Center for Vaccine Development at the University of Maryland School of Medicine in Baltimore. Recruitment has begun for the safety and efficacy study that will involve some 104 volunteers, with inoculation of the first groups expected to begin in mid-May.

"Initiation of this trial expands the spectrum of malaria vaccines in clinical development today," said Dr. Christian Loucq, Director of MVI. "This trial marks a major achievement in a collaborative development effort that aims to determine whether Sanaria's vaccine candidate is safe and effective."

While most malaria vaccines in clinical development consist of recombinant or genetically engineered proteins that represent small portions of the parasite, Sanaria's Plasmodium falciparum sporozoite vaccine candidate contains a weakened form of the entire malaria parasite. While unique to the malaria vaccine field
'/>"/>

SOURCE Sanaria Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
2. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
3. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
4. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
5. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
6. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
7. VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
8. Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye
9. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
10. Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
11. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 1, 2015 Jintian Pharmaceutical Group Limited ("Jintian ... Mr. Jin Dongtao, chairman and executive director purchased 40,000,000 ... of the existing entire issued share capital of the ... with the total amount of approximately HK$113 million. Upon ... will increase from 45.17% to 47.17%. ...
(Date:4/1/2015)... 1, 2015  For many businesses and industries just ... the case, having the right management software can be ... better than software solutions company TraxStar Technologies , ... the company announced the release of the newest version ... "QATrax ...
(Date:4/1/2015)... WAYNE, Pa. , April 1, 2015 /PRNewswire/ ... fully integrated specialty pharmaceutical company focused on developing, ... the pricing of an offering of $60.0 million ... due 2020 (the "notes") in a private placement ... under the Securities Act of 1933, as amended ...
Breaking Medicine Technology:Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7
... , FRANKLIN LAKES, N.J., Dec. 29 ... matrix engineering, announced today that Dr. Shu-Tung Li, the ... as New Jersey,s 2009 Executive of the Year, an ... and Mattia, Certified Public Accountants and Consultants. In ...
... , , , , ... developer of medical device technology for the safe handling, ... Webinar program supporting its culture of safety initiative for ... Culture of Safety in Pharmacy: Lessons Learned," features an ...
Cached Medicine Technology:Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year and Company Named Sixteenth Fastest Growing Company 2Baxa Corporation to Sponsor Free Culture of Safety Webinar 2Baxa Corporation to Sponsor Free Culture of Safety Webinar 3
(Date:4/1/2015)... Royal River Natural Foods, a locally-owned independent ... that found the amino acid creatine, which athletes typically use ... blood pressure. , The report is part of ... Being® ,” which Royal River Natural Foods publishes each month ... learn the latest in nutrition science. Also in the April ...
(Date:4/1/2015)... April 01, 2015 Bird B Gone, ... and residential applications now offers a complete line of ... range of bird netting products quickly, safely and efficiently. ... success of any bird netting installation. It’s important to ... planning stages of a project. This includes deciding whether ...
(Date:4/1/2015)... New Jersey Governor First Spouse ... Spouses from across the country in sponsoring the ... World Down Syndrome Day(WDSD), to increase awareness of, ... of Down syndrome cognition research. , In addition ... American Samoa, Arizona, California, Colorado, Delaware, Florida, Guam, ...
(Date:4/1/2015)... It all began at home in the kitchen of Shoosha ... mission to create a line of skincare for moms and ... Now, Shoosha Truly Organic is the only complete line of ... contain a minimum 95% certified organic ingredients, for babies and ... be 40% thinner than adults and of course much more ...
(Date:4/1/2015)... WA (PRWEB) April 01, 2015 ... and patient scheduling platform, today announced that CEO Joel ... 2015 Annual HIMSS Conference & Exhibition in Chicago, ... Revenue Growth with Better Provider Care Coordination Strategies ” ... 16 at 12 p.m. CDT. More than 38,000 healthcare ...
Breaking Medicine News(10 mins):Health News:New Study Finds Strength-Building Supplement Improves Circulation, Retailer Reports 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 3Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4
... it,s said that someone is depressed. But commonly, true ... symptoms. These can include anxiety, poor attention and concentration, ... depression researchers have sought to identify the individual brain ... of so many symptoms suggested to UCLA researchers that ...
... -- Rapid diagnostic influenza tests provide an accurate diagnosis, and ... for patients and help prevent the spread of the illness, ... just beginning and, despite the late start, is expected to ... patients will recover, but up to 500,000 will die, with ...
... up by the Vall d,Hebron Institute of Oncology (VHIO) heralds ... a parallel dimension to existing treatment options. The data, published ... that by combining two drugs that had already been used ... they boost each other,s efficacy and at the same time ...
... , MONDAY, Feb. 27 (HealthDay News) -- The American Academy ... ages 11 and 12 receive the three-dose vaccine for the ... and recommended for girls and young women since 2006, because ... cancers thought to be caused by HPV have increased, including ...
... Randy Dotinga HealthDay Reporter , MONDAY, Feb. 27 ... direction, you may want to look out. That,s the message ... drive expensive cars are more likely to cut off pedestrians ... focus on driving habits, either. Other lab-based experiments done by ...
... who receive new organs before the age of 55 and ... transplants a year are significantly more likely than other people ... Johns Hopkins research suggests. Examining data from the more ... and 1999, researchers found that roughly half were still alive ...
Cached Medicine News:Health News:Hyperactivity in brain may explain multiple symptoms of depression 2Health News:Rapid Flu Tests a Good First Step: Study 2Health News:A giant little step in cancer treatment opening up new therapeutic horizons 2Health News:Pediatricians Renew Call for HPV Vaccine for Boys 2Health News:Pediatricians Renew Call for HPV Vaccine for Boys 3Health News:Are the Rich Really Different From You and Me? 2Health News:Are the Rich Really Different From You and Me? 3Health News:Younger patients more likely to live a decade or longer after heart transplant 2Health News:Younger patients more likely to live a decade or longer after heart transplant 3
... Stand Magnifier offers versatility across a ... lens and the light are adjustable. ... hand held objects can be worked ... parallel to the work surface, lay ...
... aplanatic lens is made of ... system consisting of two plano-convex ... defined, distortion-free image. This lens ... patients with macular degeneration because ...
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
Replacement block for Tanne corneal punch....
Medicine Products: